T 0990/09 (Cell culture medium/BAXTER) of 03.07.2012
- European Case Law Identifier
- ECLI:EP:BA:2012:T099009.20120703
- Date of decision
- 3 July 2012
- Case number
- T 0990/09
- Petition for review of
- -
- Application number
- 00969319.3
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Medium for the protein-free and serum-free cultivation of cells
- Applicant name
- Baxter Aktiengesellschaft
- Opponent name
- Merck Serono SA
Maxygen Inc.
Sigma-Aldrich Co.
Kerry Ingredients (UK) Limited
Novo Nordisk A/S
F.Hoffmann-La Roche AG
Novartis AG
Campina Nederland Holding B.V. - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 54Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Admission of the main request and auxiliary request I filed at the oral proceedings (yes)
Auxiliary request I: added matter (no)
Novelty (yes)
Remittal (yes) - Catchword
- -
- Cited cases
- T 0472/92
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance for further prosecution based on auxiliary request I filed at the oral proceedings.